CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
Our COVID-19 Evidence Portal contains the latest COVID-19 information from CADTH and other respected organizations. Content is updated daily to reflect the rapidly changing and increasing international scientific evidence related to this disease.
The following is a summary of the most recent information posted to our COVID-19 portal.
Date: March 8, 2021
Time: 11:30 a.m. to 12:30 p.m. EST
Registration is required to attend this no-cost event.
- Join us on International Women’s Day 2021 for this special webinar, with guest speakers Dr. Olga Bougie (Queen’s University) and Dr. Innie Chen (University of Ottawa).
Our speakers will explore how the COVID 19 pandemic has exacerbated gender inequality both in Canada and on a global scale, in addition to highlighting advocacy interventions to foster pandemic management and recovery
- Tocilizumab and sarilumab are classified as humanized monoclonal antibodies against the interleukin-6 receptor and are used in rheumatology.
- CADTH has conducted a Technology Review (updated on February 4, 2021) on tocilizumab and sarilumab for their potential use in managing COVID-19.
- This report (updated on February 19, 2021) provides information on ongoing randomized controlled trials of drugs being investigated to treat or prevent COVID-19.
- It will be updated every 2 weeks.
- Ongoing trials of vaccines and plasma-based therapies are addressed in separate CADTH reports.
Visit our COVID-19 news page to stay on top of all the emerging information we are monitoring and updating.
CADTH Literature Searching Tools
CADTH is pleased to showcase additional COVID-19 resources from our partner organizations and the Canadian federal, provincial, and territorial governments’ health jurisdictions:
CAN’T FIND WHAT YOU NEED? LET US KNOW
Canadian ministries and departments of health, publicly funded organizations responsible for health service delivery, and clinical society stakeholders are encouraged to submit a request or contact their CADTH Liaison Officer. We’re here to help.